Hide metadata

dc.date.accessioned2023-12-05T16:28:40Z
dc.date.available2023-12-05T16:28:40Z
dc.date.created2023-11-14T13:11:22Z
dc.date.issued2023
dc.identifier.citationØsterås, Nina Aas, Eline Moseng, Tuva van Bodegom-Vos, Leti Dziedzic, Krysia Natvig, Bård Røtterud, Jan H Vlieland, Thea Vliet Furnes, Ove Nord Fenstad, Anne Marie Hagen, Kåre Birger . Longer-term quality of care, effectiveness, and cost-effectiveness of implementing a model of care for osteoarthritis: A cluster-randomized controlled trial. Osteoarthritis and Cartilage. 2023
dc.identifier.urihttp://hdl.handle.net/10852/106154
dc.description.abstractObjective To assess the quality of care, effectiveness, and cost-effectiveness over 12 months after implementing a structured model of care for hip and knee osteoarthritis (OA) in primary healthcare as compared to usual care. Design In this pragmatic cluster-randomized, controlled trial with a stepped-wedge cohort design, we recruited 40 general practitioners (GPs), 37 physiotherapists (PTs), and 393 patients with symptomatic hip or knee OA from six municipalities (clusters) in Norway. The model included the delivery of a 3-hour patient education and 8–12 weeks individually tailored exercise programs, and interactive workshops for GPs and PTs. At 12 months, the patient-reported quality of care was assessed by the OsteoArthritis Quality Indicator questionnaire (16 items, pass rate 0–100%, 100%=best). Costs were obtained from patient-reported and national register data. Cost-effectiveness at the healthcare perspective was evaluated using incremental net monetary benefit (INMB). Results Of 393 patients, 109 were recruited during the control periods (control group) and 284 were recruited during interventions periods (intervention group). At 12 months the intervention group reported statistically significant higher quality of care compared to the control group (59% vs. 40%; mean difference: 17.6 (95% confidence interval [CI] 11.1, 24.0)). Cost-effectiveness analyses showed that the model of care resulted in quality-adjusted life-years gained and cost-savings compared to usual care with mean INMB €2020 (95% CI 611, 3492) over 12 months. Conclusions This study showed that implementing the model of care for OA in primary healthcare, improved quality of care and showed cost-effectiveness over 12 months compared to usual care.
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleLonger-term quality of care, effectiveness, and cost-effectiveness of implementing a model of care for osteoarthritis: A cluster-randomized controlled trial
dc.title.alternativeENEngelskEnglishLonger-term quality of care, effectiveness, and cost-effectiveness of implementing a model of care for osteoarthritis: A cluster-randomized controlled trial
dc.typeJournal article
dc.creator.authorØsterås, Nina
dc.creator.authorAas, Eline
dc.creator.authorMoseng, Tuva
dc.creator.authorvan Bodegom-Vos, Leti
dc.creator.authorDziedzic, Krysia
dc.creator.authorNatvig, Bård
dc.creator.authorRøtterud, Jan H
dc.creator.authorVlieland, Thea Vliet
dc.creator.authorFurnes, Ove Nord
dc.creator.authorFenstad, Anne Marie
dc.creator.authorHagen, Kåre Birger
cristin.unitcode185,52,11,0
cristin.unitnameAvdeling for helseledelse og helseøkonomi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2196473
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Osteoarthritis and Cartilage&rft.volume=&rft.spage=&rft.date=2023
dc.identifier.jtitleOsteoarthritis and Cartilage
dc.identifier.pagecount0
dc.identifier.doihttps://doi.org/10.1016/j.joca.2023.10.003
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1063-4584
dc.type.versionPublishedVersion
dc.relation.projectNFR/328657


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International